Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The compan…
Drug Manufacturers - General
US, New York [HQ]
BMY/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18,808.00 | 19,484.00 | 21,244.00 | 17,621.00 | 16,385.00 | 15,879.00 | 16,560.00 | 19,427.00 | 20,776.00 | 22,561.00 | 26,145.00 | 42,518.00 | 46,385.00 | 46,159.00 | 45,006.00 | |
|
EPS
|
5.38 | 1.81 | 2.18 | 1.17 | 1.56 | 1.21 | 0.97 | 2.67 | 0.61 | 3.03 | 2.02 | -3.98 | 3.15 | 2.97 | 3.88 | |
| Diluted in mil. | 5.37 | 1.80 | 2.16 | 1.16 | 1.54 | 1.20 | 0.97 | 2.65 | 0.61 | 3.03 | 2.01 | -3.98 | 3.12 | 2.95 | 3.86 | |
|
Profit
|
13,668.00 | 14,207.00 | 15,646.00 | 13,011.00 | 11,766.00 | 11,947.00 | 12,651.00 | 14,481.00 | 14,710.00 | 16,014.00 | 18,067.00 | 30,745.00 | 36,445.00 | 36,022.00 | 34,313.00 | |
| Gross Margin | 72.67 | 72.92 | 73.65 | 73.84 | 71.81 | 75.24 | 76.39 | 74.54 | 70.80 | 70.98 | 69.10 | 72.31 | 78.57 | 78.04 | 76.24 | |
| Pre Tax | 5,602.00 | 6,071.00 | 6,981.00 | 2,340.00 | 2,891.00 | 2,381.00 | 2,167.00 | 5,915.00 | 5,131.00 | 6,010.00 | 4,975.00 | -6,871.00 | 8,098.00 | 7,713.00 | 8,440.00 | |
| Profit Margin | 29.79 | 31.16 | 32.86 | 13.28 | 17.64 | 14.99 | 13.09 | 30.45 | 24.70 | 26.64 | 19.03 | -16.16 | 17.46 | 16.71 | 18.75 | |
| ETR | 21.10 | 25.66 | 24.65 | -6.88 | 10.76 | 14.78 | 22.01 | 23.80 | 81.00 | 17.15 | 30.45 | -30.91 | 13.39 | 17.74 | 4.74 | |
| Net | 10,612.00 | 3,102.00 | 3,709.00 | 1,960.00 | 2,563.00 | 2,004.00 | 1,624.00 | 4,457.00 | 1,007.00 | 4,952.00 | 3,439.00 | -8,995.00 | 6,994.00 | 6,327.00 | 8,025.00 | |
| Profit Margin | 56.42 | 15.92 | 17.46 | 11.12 | 15.64 | 12.62 | 9.81 | 22.94 | 4.85 | 21.95 | 13.15 | -21.16 | 15.08 | 13.71 | 17.83 | |
| EBITDA | 4,311.00 | 6,575.00 | 7,126.00 | 4,360.00 | 3,230.00 | 2,134.00 | 2,434.00 | 5,617.00 | 5,718.00 | 6,071.00 | 6,599.00 | 14,816.00 | 20,182.00 | 19,923.00 | 19,177.00 | |
| EBITDA Margin | 22.92 | 33.75 | 33.54 | 24.74 | 19.71 | 13.44 | 14.70 | 28.91 | 27.52 | 26.91 | 25.24 | 34.85 | 43.51 | 43.16 | 42.61 | |
| Operating Income | 5,738.00 | 5,605.00 | 6,647.00 | 3,932.00 | 2,931.00 | 1,714.00 | 1,730.00 | 4,539.00 | 3,450.00 | 5,118.00 | 5,464.00 | 5,128.00 | 10,159.00 | 10,328.00 | 17,242.00 | |
| Operating Margin | 30.51 | 28.77 | 31.29 | 22.31 | 17.89 | 10.79 | 10.45 | 23.36 | 16.61 | 22.69 | 20.90 | 12.06 | 21.90 | 22.37 | 38.31 | |
| Interest Income | 54.00 | 75.00 | 91.00 | - - | - - | - - | - - | - - | - - | - - | 464.00 | 121.00 | 120.00 | 171.00 | 449.00 | |
| Loss | -14,001.00 | -12,984.00 | -14,209.00 | -13,689.00 | -13,454.00 | -14,165.00 | -14,830.00 | -14,888.00 | -17,326.00 | -17,443.00 | -20,232.00 | -40,341.00 | -37,848.00 | -37,055.00 | -36,811.00 | |
| Cost of Revenue | -5,140.00 | -5,277.00 | -5,598.00 | -4,610.00 | -4,619.00 | -3,932.00 | -3,909.00 | -4,946.00 | -6,066.00 | -6,547.00 | -8,078.00 | -11,773.00 | -9,940.00 | -10,137.00 | -10,693.00 | |
|
Operating Expenses
|
-8,861.00 | -7,707.00 | -8,611.00 | -9,079.00 | -8,835.00 | -10,233.00 | -10,921.00 | -9,942.00 | -11,260.00 | -10,896.00 | -12,154.00 | -28,568.00 | -27,908.00 | -26,918.00 | -26,118.00 | |
| R&D | -3,647.00 | -3,566.00 | -3,839.00 | -3,904.00 | -3,731.00 | -4,534.00 | -5,920.00 | -4,940.00 | -6,411.00 | -6,345.00 | -6,148.00 | -11,143.00 | -10,195.00 | -9,509.00 | -9,299.00 | |
| G&A | -4,078.00 | -3,559.00 | -4,203.00 | -158.00 | -165.00 | -877.00 | -160.00 | -91.00 | -162.00 | - - | - - | - - | - - | - - | -6,372.00 | |
| SG&A | -5,214.00 | -4,536.00 | -5,160.00 | -5,175.00 | -5,104.00 | -5,699.00 | -5,001.00 | -5,002.00 | -4,849.00 | -4,551.00 | -4,871.00 | -7,661.00 | -7,690.00 | -7,814.00 | -7,772.00 | |
| S&M | -1,136.00 | -977.00 | -957.00 | -5,017.00 | -4,939.00 | -4,822.00 | -4,841.00 | -4,911.00 | -4,687.00 | -4,551.00 | -4,871.00 | -7,661.00 | -7,690.00 | -7,814.00 | -1,400.00 | |
| Depreciation and Amortization | -707.00 | -744.00 | -801.00 | -681.00 | -763.00 | -467.00 | -376.00 | -382.00 | -789.00 | -637.00 | -1,746.00 | -10,380.00 | -10,686.00 | -10,276.00 | -9,760.00 | |
| Interest Expenses | -184.00 | -145.00 | -145.00 | -182.00 | -199.00 | -203.00 | -184.00 | -167.00 | -196.00 | -183.00 | -656.00 | -1,420.00 | -1,334.00 | -1,232.00 | -1,166.00 | |
| Other Expenses | -925.00 | -359.00 | -45.00 | -1,410.00 | -159.00 | -870.00 | -621.00 | -1,543.00 | -1,877.00 | -1,075.00 | -489.00 | -11,999.00 | -2,061.00 | -2,615.00 | -1,411.00 | |
|
WA Shares Outstanding
|
1,974.00 | 1,713.00 | 1,700.00 | 1,670.00 | 1,644.00 | 1,657.00 | 1,667.00 | 1,671.00 | 1,645.00 | 1,633.00 | 1,705.00 | 2,258.00 | 2,221.00 | 2,130.00 | 2,069.00 | |
| Diluted | 1,978.00 | 1,727.00 | 1,717.00 | 1,688.00 | 1,662.00 | 1,670.00 | 1,679.00 | 1,680.00 | 1,652.00 | 1,637.00 | 1,712.00 | 2,258.00 | 2,245.00 | 2,146.00 | 2,078.00 |